HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Juan Carlos Calvo Selected Research

Mifepristone (RU 486)

4/2011Classical membrane progesterone receptors in murine mammary carcinomas: agonistic effects of progestins and RU-486 mediating rapid non-genomic effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Juan Carlos Calvo Research Topics

Disease

16Neoplasms (Cancer)
04/2024 - 04/2011
5Breast Neoplasms (Breast Cancer)
04/2024 - 01/2017
4Choriocarcinoma
07/2010 - 02/2007
3Prostatic Neoplasms (Prostate Cancer)
07/2019 - 01/2012
2Sarcoma (Soft Tissue Sarcoma)
04/2023 - 11/2022
2Kidney Neoplasms (Kidney Cancer)
01/2022 - 09/2019
2Body Weight (Weight, Body)
04/2011 - 06/2004
1Melanoma (Melanoma, Malignant)
01/2024
1Microsatellite Instability
10/2023
1Osteosarcoma (Osteogenic Sarcoma)
11/2022
1Stomach Neoplasms (Stomach Cancer)
10/2022
1Alcoholism (Alcohol Abuse)
02/2022
1Hyperplasia
01/2019
1Neoplasm Metastasis (Metastasis)
04/2016
1Leukemia
09/2011
1Carcinoma (Carcinomatosis)
04/2011
1Obesity
01/2011
1Primary Ovarian Insufficiency
07/2004
1Acidosis
06/2004

Drug/Important Bio-Agent (IBA)

8Conditioned Culture MediaIBA
01/2023 - 02/2013
4LeptinIBA
07/2010 - 02/2007
2LipidsIBA
04/2024 - 01/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2024 - 02/2024
2CholesterolIBA
04/2024 - 02/2024
2EnzymesIBA
02/2024 - 06/2004
2VimentinIBA
01/2021 - 09/2019
2Proteins (Proteins, Gene)FDA Link
01/2019 - 09/2011
2Metalloproteases (Metalloproteinases)IBA
02/2013 - 01/2012
1Oxidoreductases (Dehydrogenase)IBA
02/2024
1Coenzyme A (CoA)IBA
02/2024
1Immune Checkpoint InhibitorsIBA
01/2024
1AntigensIBA
01/2024
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023
1VaccinesIBA
04/2023
1Biomarkers (Surrogate Marker)IBA
04/2023
1Sorafenib (BAY 43-9006)FDA Link
11/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2022
1regorafenibIBA
11/2022
1apatinibIBA
11/2022
1lenvatinibIBA
11/2022
1cabozantinibIBA
11/2022
1Tyrosine Kinase InhibitorsIBA
10/2022
1Monoclonal AntibodiesIBA
10/2022
1PlatinumIBA
10/2022
1Immunoconjugates (Immunoconjugate)IBA
10/2022
1Ethanol (Ethyl Alcohol)IBA
02/2022
1heliantriol B2IBA
07/2019
1TriterpenesIBA
07/2019
1lupeolIBA
07/2019
1LupanesIBA
07/2019
1CytokinesIBA
07/2018
1PhytochemicalsIBA
08/2017
1Versicans (Versican)IBA
01/2017
1ParaffinIBA
04/2016
1Indicators and Reagents (Reagents)IBA
04/2016
1AntibodiesIBA
04/2016
1AndrogensIBA
01/2012
1Complementary DNA (cDNA)IBA
09/2011
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2011
1Growth Factor ReceptorsIBA
09/2011
1Progestins (Progestagens)IBA
04/2011
1Mifepristone (RU 486)FDA Link
04/2011
1Progesterone Receptors (Progesterone Receptor)IBA
04/2011
1ProgesteroneFDA LinkGeneric
04/2011
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2009
1Follicle Stimulating Hormone (Follitropin)FDA Link
07/2004
1Immunoglobulins (Immunoglobulin)IBA
07/2004
1GlucocorticoidsIBA
06/2004
1CorticosteroneIBA
06/2004

Therapy/Procedure

5Therapeutics
01/2024 - 10/2022
3Immunotherapy
10/2023 - 10/2022
2Drug Therapy (Chemotherapy)
10/2023 - 10/2022
1Cell- and Tissue-Based Therapy (Cell Therapy)
04/2023